HealthTrans saves US consumers $182M

22 June 2008

Since 2006, the HealthTrans Access prescription discount program in the USA has provided uninsured/underinsured populations needed access to critical medication, saving these consumers more than $182.0 million. The HealthTrans Access discount drug card provides cardholders with discounts ranging from 10% to 85% off the cost of generic and brand name prescription drugs at more than 55,000 pharmacies nationwide. The average HealthTrans Access drug price is $31.79, which is a 57% savings over the national average medication price of $75, as stated by the National Association of Chain Drug Stores," said Michael Oshins, HealthTrans senior vice president of consumer directed programs.

HealthTrans says its offering differs from some of the emerging big-box retailer low-cost and state-run programs because the list of covered medications is far more comprehensive, as there are no exclusions.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight